Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BGI Americas is the North American subsidiary of BGI Group, one of the world's largest genomics organizations. Headquartered in Cambridge, Massachusetts, the company provides a comprehensive suite of next-generation sequencing (NGS) and bioinformatics services to academic researchers, pharmaceutical companies, and clinical laboratories. Utilizing its proprietary DNBseq™ sequencing technology, BGI Americas delivers high-quality genomic data for applications ranging from basic research to precision medicine and agricultural genomics. The company operates state-of-the-art laboratories in the United States and focuses on advancing scientific discovery through collaborative partnerships and innovative genomic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BG North America.